- ￥1195 - 12355
- 翌圣生物
- 94509ES
- 2026年10月15日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
源叶生物 十万种现货试剂速发，品质稳、品类全，实验不再等！Takara 秋促来袭，提取+反转录+定量套装仅 1200 元abinScience 体内级抗体 全年锁价 低至 ￥1200阿拉丁 22万+ 科研级产品现货速发，品质严控、科研无忧- 详细信息
- 文献和实验
- 技术资料
- 英文名：
Recombinant Human Coagulation Factor III/Tissue Factor Protein,His Tag
- 保存条件：
-25 ~ -15℃保存，收到货之后有效期1年。 复溶后， 无菌条件下，-85 ~ -65℃保存，3个月有效期。
- 规格：
100 μg(94509ES60)/500 μg(94509ES76)/25 μg(94509ES25)
| 规格： | 100 μg(94509ES60) | 产品价格： | ￥3585 |
|---|---|---|---|
| 规格： | 500 μg(94509ES76) | 产品价格： | ￥12355 |
| 规格： | 25 μg(94509ES25) | 产品价格： | ￥1195 |
产品属性：
| 产品别称 | TF, Coagulation Factor III,Tissue factor, CD142 |
| 种属 | Human |
| 表达序列 | Ser33-Glu251 |
| Accession | P13726-1 |
| 标签 | C-His |
| 表达系统 | HEK293 |
| 分子量 | The protein has a predicted MW of 25.89 kDa. Due to glycosylation, the protein migrates to 40-50 kDa based on SDS-PAGE result. |
| 纯度 | > 95% as determined by SDS-PAGE and HPLC. |
| 内毒素 | < 1.0 EU per μg by the LAL method. |
| 制剂 | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
| 外观 | Lyophilized Powder |
| 生物活性 | 【ELISA Data】 Immobilized Human Coagulation Factor III, His Tag at 2μg/ml (100μl/well) on the plate. Dose response curve for Anti-Coagulation Factor III Antibody, hFc Tag with the EC50 of 8.8ng/ml determined by ELISA. |
| 复溶方法 | 开盖之前，先离心。使用蒸馏水复溶冻干的蛋白质，复溶浓度超过100 μg/mL。建议首次使用时将蛋白分装为每次实验用量，避免反复冻融。 |
产品特色：
高纯度、高活性、低内毒素、高批间一致性
储存条件：
-25 ~ -15℃保存，收到货之后有效期1年。 复溶后， 无菌条件下，-85 ~ -65℃保存，3个月有效期。
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Use of Human Hepatocytes to Investigate Blood Coagulation Factor
Coagulation is the complex process by which activation of plasmatic haemostasis proteins ends up with the generation of fibrin. Most of the plasma coagulation proteins are synthesized in hepatocytes. The aim of this chapter
Identification of Mutations in the Human Factor VII Gene
It has been recognized from the early 1800s that activation of coagulation can be initiated by the exposure of subendothelial layers (tissue factor), but it was the 1940s before factor VII (FVII) was included in this event
Laboratory Methods for the Assay of Tissue Factor Pathway Inhibitor in Human Plasma
Tissue factor pathway inhibitor (TFPI) is being assayed with increasing frequency by researchers attempting to further understand the complexities of the coagulation system. There are a number of methods available for measurement of TFPI
技术资料暂无技术资料 索取技术资料
